These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fenoterol, asthma deaths, and asthma severity. Pearce N, Burgess C, Crane J, Beasley R. Chest; 1997 Oct; 112(4):1148-50. PubMed ID: 9377940 [No Abstract] [Full Text] [Related]
23. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K, Noonan M, Silkoff PE, Uryniak T. Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [Abstract] [Full Text] [Related]
24. [The beta-2-agonists in asthma in infants and young children]. Dubus JC, Mély L, Stremler-Lebel N, Chabrol B. Arch Pediatr; 2002 Aug; 9 Suppl 3():384s-389s. PubMed ID: 12205813 [Abstract] [Full Text] [Related]
28. The use of inhaled formoterol in the treatment of asthma. Berger WE. Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777 [Abstract] [Full Text] [Related]
32. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, Culling C, Windom H, Beasley R. Thorax; 1990 Mar; 45(3):170-5. PubMed ID: 2330548 [Abstract] [Full Text] [Related]
33. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. Tripp K, McVicar WK, Nair P, Corren J, Pleskow WW, Goodwin E, Baumgartner RA, Hanrahan JP. J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886 [Abstract] [Full Text] [Related]
35. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cates CJ, Jaeschke R, Schmidt S, Ferrer M. Cochrane Database Syst Rev; 2013 Jun 07; (6):CD006924. PubMed ID: 23744625 [Abstract] [Full Text] [Related]
36. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews. Craig SS, Dalziel SR, Powell CV, Graudins A, Babl FE, Lunny C. Cochrane Database Syst Rev; 2020 Aug 05; 8(8):CD012977. PubMed ID: 32767571 [Abstract] [Full Text] [Related]
37. The use of beta-agonists and the risk of death and near death from asthma. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS. N Engl J Med; 1992 Feb 20; 326(8):501-6. PubMed ID: 1346340 [Abstract] [Full Text] [Related]
38. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I, Hall IP, McFarlane LC, Lipworth BJ. J Allergy Clin Immunol; 1998 Mar 20; 101(3):337-41. PubMed ID: 9525449 [Abstract] [Full Text] [Related]
39. Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma. Ram FS, Brocklebank DM, White J, Wright JP, Jones PW. Cochrane Database Syst Rev; 2002 Mar 20; 2002(1):CD002158. PubMed ID: 11869625 [Abstract] [Full Text] [Related]
40. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. Chan J, Hui RL, Spence MM. J Manag Care Pharm; 2007 Mar 20; 13(1):21-7. PubMed ID: 17269833 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]